Medtronic USA Inc.

Medtronic USA Inc. is a foreign-owned, for-profit medical device manufacturer headquartered in Minneapolis, Minnesota, that supplies surgical implants, prosthetic devices, cardiovascular intervention equipment, and surgical navigation systems to the federal government as a prime contractor across full-and-open competitive procurements with no set-aside participation.

Over the past five years, Medtronic has accumulated 15,671 federal prime awards valued at $1.17 billion in combined potential value, with obligated dollars reaching $377.3 million as of mid-2026. The vendor competes exclusively in unrestricted full-and-open categories across 34 distinct customer agencies. Award volume peaked in 2024 at 1,075 awards and has moderated to 267 awards year-to-date in 2026, reflecting the seasonal and episodic nature of medical device procurement.

Customer concentration centers on the Defense Logistics Agency Troop Support Medical division and multiple Veterans Integrated Service Networks within the Department of Veterans Affairs. The DLA Medical Supply Chain accounts for 2,183 awards worth $137.2 million in combined potential value—roughly 19% of Medtronic's total federal work—anchored by a single-award Indefinite Delivery Contract (SPE2DE23DA011) valued at approximately $113 billion over five years through July 1, 2028, under which Medtronic serves as the sole provider of complete cardiovascular procedural packages to Department of Defense hospitals, research centers, and clinics nationwide. The VA's Veterans Health Administration represents diffuse but substantial demand, with VISN 10, VISN 17, VISN 7, and VISN 22 collectively placing 5,142 awards worth $145.2 million. The top five customer agencies by both award count and dollar value account for 45% of awards and 26% of combined potential value respectively, with the two rankings tracking closely—DLA and VISN 10 dominate both lists—signaling sustained, predictable demand rather than concentrated dependence on a single customer relationship.

Medtronic's primary vehicle footprint is dominated by the VA Prosthetic Implants and Appliances 2016-2021 BPA framework, which carries 9,198 task orders worth $220.9 million. The DLA SPE2DE IDC houses 2,159 task orders valued at $19.2 million. Smaller VA BPAs including FA860116A0006 (41 task orders, $4.4 million) and HT001416A0070 (31 task orders, $6.6 million) represent secondary vehicle positions. The SPE2DE contract is Medtronic's primary growth lever within the Department of Defense, providing sole-source access to cardiovascular consumables and capital equipment procurement across military healthcare. Two delivery orders under a single-award IDIQ with Veterans Integrated Service Network 9 for StealthStation S8 Surgical Navigation System maintenance (ceiling $1.12 million through July 2029) demonstrate Medtronic's position in specialized surgical navigation and imaging support to the VA.

Capability portfolio is sharply focused on medical device manufacturing and supply. Primary work includes delivery of surgical implants (spinal fusion components, deep brain stimulation devices, pacemakers, cardiac mapping systems), prosthetic devices (bone rods and screws, spinal spacers, orthopedic implants), and cardiovascular procedural packages (catheters, drug-coated balloons, stents, leads, imaging components, and ablation equipment). Secondary work includes full-service maintenance and technical support for StealthStation surgical navigation platforms and O-Arm imaging systems, with 24/7 technical support mandated under the DLA sole-source vehicle. Representative awards include a $6.685 million purchase order from VISN 17 for Affera Cardiac Mapping Ablation System hardware and consumables (June 2026), a $247,980 delivery order from VISN 9 for StealthStation S8 maintenance (July 2026), and a $113 billion five-year DLA contract ceiling for integrated cardiovascular procedural packages. Award volumes reflect high-frequency ordering patterns across multiple points of issue—DLA Medical Supply Chain issues dozens of task orders monthly in tranches of $1,000 to $110,000 per order, while VA VISNs place monthly purchase orders ranging from $15,000 to $250,000 for implant-specific acquisitions.

NAICS concentration is decisive: Surgical Appliance and Supplies Manufacturing (12,457 awards) and Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers (2,229 awards) account for the vast majority of the vendor's federal footprint, with PSC codes following the same pattern—13,235 awards under Medical and Surgical Instruments, Equipment, and Supplies (PSC 6515). This profile reflects Medtronic's pure-play positioning as a medical device manufacturer rather than a service contractor or integrator.

The recompete cliff presents modest risk: 36 awards with completion dates in the next twenty-four months carry combined potential value of $7.7 million, representing less than 1% of Medtronic's $1.17 billion total federal portfolio. Activity deceleration from 1,075 awards in 2024 to 267 awards year-to-date suggests seasonal or methodological variance rather than competitive displacement, though the vendor's absence from high-growth federal IT and systems integration vehicles limits visibility into whether consolidation is shifting demand toward larger prime integrators. Medtronic's subcontract footprint is negligible—one sub-award as a research collaborator with Washington University on an NIH grant for surgical navigation software integration—reflecting its role as a direct manufacturer and sole-source supplier rather than a systems integrator or recompetitor with prime partners.